Plain-English translation of NCT05579353 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Researchers are studying genetic molecules in colorectal cancer tissue to understand how the disease develops and spreads. By analyzing tissue samples from patients who have had colorectal cancer surgery, this study aims to identify new genetic markers that could help doctors predict which patients are at higher risk for the cancer returning or spreading, and which treatments might work best for each person.
Colorectal cancer often comes back or spreads to other parts of the body even after surgery. Right now, doctors don't have enough reliable genetic markers to predict who will have problems or to choose the most effective targeted therapies. This study hopes to find new genetic clues that could improve treatment decisions and outcomes.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would have tissue samples collected during or after your colorectal cancer surgery — this is typically done as part of routine surgical care, not an extra procedure. Researchers would then analyze these tissue samples in the laboratory to study the genetic markers. You may also be asked to provide some health and medical history information. The study is recruiting approximately 200 participants total.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
China